P J Neuvonen|E Elonen|M J Mattila - JoVE Visualize

Showing results (191-200 of 463) with videos related to

Pageof 47

Sort By:

European Journal of Clinical Pharmacology|January 1, 1997

Itraconazole moderately increases serum concentrations of oxybutynin but does not affect those of the active metaboliteE Lukkari, A Juhakoski, K Aranko, et al.

Bulletin of Environmental Contamination and Toxicology|June 15, 2023

Review of DDT, DDE, DDD, DDMU and DDMS Toxicity Data for Organisms Used in Estuarine and Marine Sediment Toxicity TestsLawrence P Burkhard, Gregory E Elonen, David R Mount

Infection|November 1, 1986

Prospective study on humoral immune response induced by fungal infection in patients with hematologic malignanciesI Kostiala, E Elonen, P Ylipaavalniemi, et al.

Acta Psychiatrica Scandinavica. Supplementum|January 1, 1990

Effects of remoxipride on psychomotor performance, alone and in combination with ethanol and diazepamM J Mattila, M E Mattila

British Medical Journal|September 23, 1978

Effect of cirrhosis of the liver on the pharmacokinetics of chlormethiazoleP J Pentikainen, P J Neuvonen, S Tarpila, et al.

The Journal of Pharmacy and Pharmacology|September 1, 1996

The effect of pH on the in-vitro dissolution of three second-generation sulphonylurea preparations: mechanism of antacid-sulphonylurea interactionP Lehto, K Laine, K T Kivistö, et al.

Acta Pharmacologica Et Toxicologica|July 1, 1979

Ascitic fluid modifying the distribution of sulphafurazole in rats with intestinal occlusionV M Venho, M J Mattila

The Journal of Antimicrobial Chemotherapy|May 8, 2000

Elimination of meropenem during continuous veno-venous haemofiltration and haemodiafiltration in patients with acute renal failureM Valtonen, E Tiula, J T Backman, et al.

Clinical Pharmacology and Therapeutics|March 4, 2011

Mechanism-based inactivation of CYP2C8 by gemfibrozil occurs rapidly in humansJ Honkalammi, M Niemi, P J Neuvonen, et al.

Stroke|July 1, 1983

Increase of low serum concentrations of high-density lipoprotein (HDL) cholesterol in TIA-patients treated with phenytoinM Kaste, A Muuronen, E A Nikkilä, et al.

Pageof 47

Showing results (191-200 of 463) with videos related to

Sort By:

Pageof 47

European Journal of Clinical Pharmacology|January 1, 1997

Itraconazole moderately increases serum concentrations of oxybutynin but does not affect those of the active metaboliteE Lukkari, A Juhakoski, K Aranko, et al.

Bulletin of Environmental Contamination and Toxicology|June 15, 2023

Review of DDT, DDE, DDD, DDMU and DDMS Toxicity Data for Organisms Used in Estuarine and Marine Sediment Toxicity TestsLawrence P Burkhard, Gregory E Elonen, David R Mount

Infection|November 1, 1986

Prospective study on humoral immune response induced by fungal infection in patients with hematologic malignanciesI Kostiala, E Elonen, P Ylipaavalniemi, et al.

Acta Psychiatrica Scandinavica. Supplementum|January 1, 1990

Effects of remoxipride on psychomotor performance, alone and in combination with ethanol and diazepamM J Mattila, M E Mattila

British Medical Journal|September 23, 1978

Effect of cirrhosis of the liver on the pharmacokinetics of chlormethiazoleP J Pentikainen, P J Neuvonen, S Tarpila, et al.

The Journal of Pharmacy and Pharmacology|September 1, 1996

The effect of pH on the in-vitro dissolution of three second-generation sulphonylurea preparations: mechanism of antacid-sulphonylurea interactionP Lehto, K Laine, K T Kivistö, et al.

Acta Pharmacologica Et Toxicologica|July 1, 1979

Ascitic fluid modifying the distribution of sulphafurazole in rats with intestinal occlusionV M Venho, M J Mattila

The Journal of Antimicrobial Chemotherapy|May 8, 2000

Elimination of meropenem during continuous veno-venous haemofiltration and haemodiafiltration in patients with acute renal failureM Valtonen, E Tiula, J T Backman, et al.

Clinical Pharmacology and Therapeutics|March 4, 2011

Mechanism-based inactivation of CYP2C8 by gemfibrozil occurs rapidly in humansJ Honkalammi, M Niemi, P J Neuvonen, et al.

Stroke|July 1, 1983

Increase of low serum concentrations of high-density lipoprotein (HDL) cholesterol in TIA-patients treated with phenytoinM Kaste, A Muuronen, E A Nikkilä, et al.

Pageof 47